Center for Scientific Review; Amended Notice of Meeting, 21359 [E8-8450]
Download as PDF
<![CDATA[
Federal Register / Vol. 73, No. 77 / Monday, April 21, 2008 / Notices
D. Pet Food Processing Standards
The AFSS initiative is intended to
cover the entire spectrum of agency
activities from preapproval of food
additives for use in feed, to establishing
limits for feed contaminants, providing
education and training, and conducting
inspections and taking enforcement
actions for ensuring compliance with
agency regulations. Some basic elements
of an animal feed safety system are
described at: https://www.fda.gov/ohrms/
dockets/98fr/03n–0312–bkg0002.pdf.
Would standards based on a riskbased, preventive, and comprehensive
feed control measures approach, such as
the approach described as an element of
FDA’s AFSS initiative, adequately
address the processing standards
requirement of section 1002(a) of
FDAAA? If so, what aspects of
procurement, processing and
distribution should be included in such
an approach? Should such standards be
developed and applied to all animal
feeds rather than be limited to pet food?
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Pregnancy and
Neonatology Study Section, June 2,
2008, 8 a.m. to June 3, 2008, 3 p.m.,
Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC, 20015 which was
published in the Federal Register on
April 4, 2008, 73 FR 18539–18542.
The meeting will be held one day
only June 2, 2008, from 8 a.m. to 5 p.m.
The meeting location remains the same.
The meeting is closed to the public.
Dated: April 14, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–8450 Filed 4–18–08; 8:45 am]
BILLING CODE 4140–01–M
III. Other Information for the Public
Meeting
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
FDA has posted additional
information for the May 13, 2008, public
meeting on the CVM Web site at https://
www.fda.gov/cvm. The agency may
make additional background material
available to the public and will post that
information on the CVM Web site as
well. Additionally, background material
relating to AFSS, including previous
drafts of the AFSS Framework
document, is available at https://
www.fda.gov/cvm/AFSS.htm.
National Institutes of Health
IV. Transcripts
rwilkins on PROD1PC63 with NOTICES
FDA will prepare a meeting transcript
that will be entered into the docket.
FDA anticipates that transcripts will be
available approximately 30 business
days after the meeting. The transcript
will also be available for public
examination at the Division of Dockets
Management (HFA–305), 5630 Fishers
Lane, rm. 1061, Rockville, MD 20852,
between 9 a.m. and 4 p.m., Monday
through Friday.
Dated: April 15, 2008.
Jeffrey Shuren,
Associate Commissioner for Policy and
Planning.
[FR Doc. 08–1155 Filed 4–16–08; 3:48 pm]
BILLING CODE 4160–01–S
VerDate Aug<31>2005
17:14 Apr 18, 2008
Jkt 214001
Office of the Director, National
Institutes of Health; Office of
Biotechnology Activities; Recombinant
DNA Research; Notice of a Meeting of
an NIH Blue Ribbon Panel
There will be a meeting of the NIH
Blue Ribbon Panel to advise on the Risk
Assessment of the National Emerging
Infectious Diseases Laboratories (NEIDL)
at the Boston Medical Center. The
meeting will be held on Friday, May 2,
2008, at the National Institutes of
Health, Building 31, Floor 6C,
Conference Room 10, 31 Center Drive,
Bethesda, Maryland 20892, from 8:30
a.m. to approximately 11:30 a.m.
The National Research Council
Committee that provided technical
input on the NIH’s Draft Supplementary
Risk Assessments and Site Suitability
Analyses for the NEIDL will participate
in discussions with Panel members
regarding the scope and design of
additional studies that may be needed to
assess risk associated with the siting
and operation of the NEIDL.
For further information concerning
this meeting contact Ms. Laurie
Lewallen, Advisory Committee
Coordinator, Office of Biotechnology
Activities, Office of the Director,
National Institutes of Health, 6705
Rockledge Drive, Room 750, Bethesda,
MD 20892–7985, 301–496–9838,
lewallla@od.nih.gov.
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
21359
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed above in
advance of the meeting. Any interested
person may file written comments with
the panel by forwarding the statement to
the Contact Person listed on this notice.
The statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
NIH campus security procedures
require that all visitor vehicles,
including taxicabs and hotel and airport
shuttles will be inspected before being
allowed on campus. Visitors will be
asked to show one form of identification
(for example, a government-issued
photo ID, driver’s license, or passport)
and to state the purpose of their visit.
An agenda and any additional
information for the meeting will be
posted on the agency’s Web site:
https://www.nih.gov/about/director/acd/
index.htm.
Background information may be
obtained by contacting NIH OBA by email oba@od.nih.gov.
Dated: April 14, 2008.
Amy P. Patterson,
Director, Office of Biotechnology Activities.
[FR Doc. E8–8474 Filed 4–18–08; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Federal Emergency
Management Agency, DHS.
ACTION: Notice; 30-day notice and
request for comments; Telephone
Survey, OMB 1660–0057, Revision of a
currently approved collection.
AGENCY:
SUMMARY: The Federal Emergency
Management Agency (FEMA) has
submitted the following information
collection to the Office of Management
and Budget (OMB) for review and
clearance in accordance with the
requirements of the Paperwork
Reduction Act of 1995. The submission
describes the nature of the information
collection, the categories of
respondents, the estimated burden (i.e.,
the time, effort and resources used by
respondents to respond) and cost, and
E:\FR\FM\21APN1.SGM
21APN1
]]>Agencies
[Federal Register Volume 73, Number 77 (Monday, April 21, 2008)]
[Notices]
[Page 21359]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-8450]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the Pregnancy
and Neonatology Study Section, June 2, 2008, 8 a.m. to June 3, 2008, 3
p.m., Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road,
NW., Washington, DC, 20015 which was published in the Federal Register
on April 4, 2008, 73 FR 18539-18542.
The meeting will be held one day only June 2, 2008, from 8 a.m. to
5 p.m. The meeting location remains the same. The meeting is closed to
the public.
Dated: April 14, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-8450 Filed 4-18-08; 8:45 am]
BILLING CODE 4140-01-M
